Integrating Immunotherapy Into Chemoradiation for NSCLC Integrating Immunotherapy Into Chemoradiation for NSCLC
Clinicians should consider timing and toxicities when adding a checkpoint inhibitor to chemoradiotherapy for NSCLC.Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Toxicology